Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

Surgical Innovations Group (SUN) Competitors

Surgical Innovations Group logo
GBX 0.45 0.00 (0.00%)
As of 05/18/2026 11:41 AM Eastern
Compare

SUN vs. EOG, BRY, MXC, HNR, and NOG

Should you buy Surgical Innovations Group stock or one of its competitors? MarketBeat compares Surgical Innovations Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Surgical Innovations Group include Europa Oil & Gas (EOG), Brady (BRY), Argent BioPharma (MXC), Highlands Natural Resources (HNR), and Nostrum Oil & Gas (NOG). These companies are all part of the "petroleum and natural gas" industry.

How does Surgical Innovations Group compare to Europa Oil & Gas?

Surgical Innovations Group (LON:SUN) and Europa Oil & Gas (LON:EOG) are both small-cap petroleum and natural gas companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends.

In the previous week, Europa Oil & Gas had 1 more articles in the media than Surgical Innovations Group. MarketBeat recorded 1 mentions for Europa Oil & Gas and 0 mentions for Surgical Innovations Group. Surgical Innovations Group's average media sentiment score of 0.00 equaled Europa Oil & Gas'average media sentiment score.

Company Overall Sentiment
Surgical Innovations Group Neutral
Europa Oil & Gas Neutral

Surgical Innovations Group has a net margin of -4.96% compared to Europa Oil & Gas' net margin of -190.16%. Surgical Innovations Group's return on equity of -6.04% beat Europa Oil & Gas' return on equity.

Company Net Margins Return on Equity Return on Assets
Surgical Innovations Group-4.96% -6.04% -3.03%
Europa Oil & Gas -190.16%-95.12%3.90%

2.8% of Surgical Innovations Group shares are held by institutional investors. Comparatively, 0.8% of Europa Oil & Gas shares are held by institutional investors. 21.5% of Surgical Innovations Group shares are held by insiders. Comparatively, 13.6% of Europa Oil & Gas shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Surgical Innovations Group has higher revenue and earnings than Europa Oil & Gas. Surgical Innovations Group is trading at a lower price-to-earnings ratio than Europa Oil & Gas, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgical Innovations Group£11.60M0.36N/A-£0.10N/A
Europa Oil & Gas£3.57M5.30-£6.78M-£0.71N/A

Surgical Innovations Group has a beta of 0.65, indicating that its stock price is 35% less volatile than the broader market. Comparatively, Europa Oil & Gas has a beta of 0.053, indicating that its stock price is 95% less volatile than the broader market.

Summary

Surgical Innovations Group beats Europa Oil & Gas on 7 of the 11 factors compared between the two stocks.

How does Surgical Innovations Group compare to Brady?

Brady (LON:BRY) and Surgical Innovations Group (LON:SUN) are both small-cap petroleum and natural gas companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Brady has a net margin of 0.00% compared to Surgical Innovations Group's net margin of -4.96%. Brady's return on equity of 0.00% beat Surgical Innovations Group's return on equity.

Company Net Margins Return on Equity Return on Assets
BradyN/A N/A N/A
Surgical Innovations Group -4.96%-6.04%-3.03%

2.8% of Surgical Innovations Group shares are owned by institutional investors. 21.5% of Surgical Innovations Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Surgical Innovations Group is trading at a lower price-to-earnings ratio than Brady, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Brady£22.16M0.00N/A-£3.70N/A
Surgical Innovations Group£11.60M0.36N/A-£0.10N/A

In the previous week, Brady's average media sentiment score of 0.00 equaled Surgical Innovations Group'saverage media sentiment score.

Company Overall Sentiment
Brady Neutral
Surgical Innovations Group Neutral

Summary

Brady and Surgical Innovations Group tied by winning 4 of the 8 factors compared between the two stocks.

How does Surgical Innovations Group compare to Argent BioPharma?

Surgical Innovations Group (LON:SUN) and Argent BioPharma (LON:MXC) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings and profitability.

Surgical Innovations Group has higher revenue and earnings than Argent BioPharma. Surgical Innovations Group is trading at a lower price-to-earnings ratio than Argent BioPharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgical Innovations Group£11.60M0.36N/A-£0.10N/A
Argent BioPharma£1.32M0.00-£17.02M-£1.66N/A

2.8% of Surgical Innovations Group shares are owned by institutional investors. Comparatively, 1.2% of Argent BioPharma shares are owned by institutional investors. 21.5% of Surgical Innovations Group shares are owned by insiders. Comparatively, 8.2% of Argent BioPharma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Surgical Innovations Group's average media sentiment score of 0.00 equaled Argent BioPharma'saverage media sentiment score.

Company Overall Sentiment
Surgical Innovations Group Neutral
Argent BioPharma Neutral

Surgical Innovations Group has a beta of 0.65, suggesting that its share price is 35% less volatile than the broader market. Comparatively, Argent BioPharma has a beta of 1.03, suggesting that its share price is 3% more volatile than the broader market.

Argent BioPharma has a net margin of 0.00% compared to Surgical Innovations Group's net margin of -4.96%. Argent BioPharma's return on equity of 0.00% beat Surgical Innovations Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Surgical Innovations Group-4.96% -6.04% -3.03%
Argent BioPharma N/A N/A -58.96%

Summary

Surgical Innovations Group beats Argent BioPharma on 6 of the 9 factors compared between the two stocks.

How does Surgical Innovations Group compare to Highlands Natural Resources?

Highlands Natural Resources (LON:HNR) and Surgical Innovations Group (LON:SUN) are both small-cap petroleum and natural gas companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, media sentiment, risk, institutional ownership and earnings.

Highlands Natural Resources has a net margin of 0.00% compared to Surgical Innovations Group's net margin of -4.96%. Highlands Natural Resources' return on equity of 0.00% beat Surgical Innovations Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Highlands Natural ResourcesN/A N/A N/A
Surgical Innovations Group -4.96%-6.04%-3.03%

Surgical Innovations Group is trading at a lower price-to-earnings ratio than Highlands Natural Resources, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Highlands Natural Resources£1.02M0.00N/A-£4.90N/A
Surgical Innovations Group£11.60M0.36N/A-£0.10N/A

In the previous week, Highlands Natural Resources' average media sentiment score of 0.00 equaled Surgical Innovations Group'saverage media sentiment score.

Company Overall Sentiment
Highlands Natural Resources Neutral
Surgical Innovations Group Neutral

2.8% of Surgical Innovations Group shares are held by institutional investors. 21.5% of Surgical Innovations Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Highlands Natural Resources and Surgical Innovations Group tied by winning 4 of the 8 factors compared between the two stocks.

How does Surgical Innovations Group compare to Nostrum Oil & Gas?

Surgical Innovations Group (LON:SUN) and Nostrum Oil & Gas (LON:NOG) are both small-cap petroleum and natural gas companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, media sentiment, dividends, profitability and analyst recommendations.

2.8% of Surgical Innovations Group shares are held by institutional investors. Comparatively, 9.7% of Nostrum Oil & Gas shares are held by institutional investors. 21.5% of Surgical Innovations Group shares are held by company insiders. Comparatively, 34.5% of Nostrum Oil & Gas shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Surgical Innovations Group has higher earnings, but lower revenue than Nostrum Oil & Gas. Surgical Innovations Group is trading at a lower price-to-earnings ratio than Nostrum Oil & Gas, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgical Innovations Group£11.60M0.36N/A-£0.10N/A
Nostrum Oil & Gas£121.19M0.04-£121.71M-£235.00N/A

Surgical Innovations Group has a net margin of -4.96% compared to Nostrum Oil & Gas' net margin of -182.05%. Nostrum Oil & Gas' return on equity of 109.47% beat Surgical Innovations Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Surgical Innovations Group-4.96% -6.04% -3.03%
Nostrum Oil & Gas -182.05%109.47%1.53%

Surgical Innovations Group has a beta of 0.65, meaning that its stock price is 35% less volatile than the broader market. Comparatively, Nostrum Oil & Gas has a beta of 0.718, meaning that its stock price is 28% less volatile than the broader market.

In the previous week, Nostrum Oil & Gas had 1 more articles in the media than Surgical Innovations Group. MarketBeat recorded 1 mentions for Nostrum Oil & Gas and 0 mentions for Surgical Innovations Group. Surgical Innovations Group's average media sentiment score of 0.00 equaled Nostrum Oil & Gas'average media sentiment score.

Company Overall Sentiment
Surgical Innovations Group Neutral
Nostrum Oil & Gas Neutral

Nostrum Oil & Gas has a consensus target price of GBX 4, suggesting a potential upside of 24.96%. Given Nostrum Oil & Gas' stronger consensus rating and higher possible upside, analysts plainly believe Nostrum Oil & Gas is more favorable than Surgical Innovations Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surgical Innovations Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Nostrum Oil & Gas
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Nostrum Oil & Gas beats Surgical Innovations Group on 10 of the 13 factors compared between the two stocks.

Get Surgical Innovations Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SUN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SUN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SUN vs. The Competition

Export
MetricSurgical Innovations GroupMedical Devices IndustryMedical SectorLON Exchange
Market Cap£4.20M£2.07B£6.25B£2.76B
Dividend Yield2.63%2.67%2.80%6.15%
P/E Ratio-4.5013.9220.86365.85
Price / Sales0.36129.89550.9188,116.34
Price / Cash5.0315.9927.4827.89
Price / Book0.454.569.677.62
Net IncomeN/A£144.75M£3.56B£5.89B
7 Day Performance-7.60%-1.30%-1.69%0.42%
1 Month Performance-3.64%0.96%-2.65%0.56%
1 Year Performance-28.00%7.52%30.03%84.41%

Surgical Innovations Group Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SUN
Surgical Innovations Group
N/AGBX 0.45
flat		N/A-33.0%£4.20M£11.60MN/A80
EOG
Europa Oil & Gas
N/AGBX 1.30
-7.1%		N/A+104.7%£17.11M£3.57MN/A2,850
BRY
Brady
N/AN/AN/AN/A£15.17M£22.16MN/A1,370
MXC
Argent BioPharma
N/AN/AN/AN/A£9.65M£1.32MN/A5
HNR
Highlands Natural Resources
N/AN/AN/AN/A£6.95M£1.02MN/A16

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:SUN) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel